BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33336901)

  • 1. Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.
    Mokhtari Y; Pourbagheri-Sigaroodi A; Zafari P; Bagheri N; Ghaffari SH; Bashash D
    J Cell Mol Med; 2021 Jan; 25(2):639-651. PubMed ID: 33336901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important aspects of Toll-like receptors, ligands and their signaling pathways.
    Chang ZL
    Inflamm Res; 2010 Oct; 59(10):791-808. PubMed ID: 20593217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: new regulators of Toll-like receptor signalling pathways.
    He X; Jing Z; Cheng G
    Biomed Res Int; 2014; 2014():945169. PubMed ID: 24772440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.
    Medvedev AE
    J Interferon Cytokine Res; 2013 Sep; 33(9):467-84. PubMed ID: 23675778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous toll-like receptor ligands and their biological significance.
    Yu L; Wang L; Chen S
    J Cell Mol Med; 2010 Nov; 14(11):2592-603. PubMed ID: 20629986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of toll-like receptors (TLRs) in pan-cancer.
    Huang R; Sun Z; Xian S; Song D; Chang Z; Yan P; Zhang J; Yin H; Zheng Z; Hu P; Li Z; Huang D; Liu Y; Jiang C; Li M; Li S; Meng T; Yang D; Huang Z
    Ann Med; 2022 Dec; 54(1):1918-1937. PubMed ID: 35801728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIR-containing adaptors in Toll-like receptor signalling.
    Jenkins KA; Mansell A
    Cytokine; 2010 Mar; 49(3):237-44. PubMed ID: 19264502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of toll-like receptors in tissue repair and tumorigenesis.
    Rakoff-Nahoum S; Medzhitov R
    Biochemistry (Mosc); 2008 May; 73(5):555-61. PubMed ID: 18605980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Yin and Yang of Toll-like receptors in cancer.
    Pradere JP; Dapito DH; Schwabe RF
    Oncogene; 2014 Jul; 33(27):3485-95. PubMed ID: 23934186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
    Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
    Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin, a toll-like receptor inhibitor: Current status and future perspectives.
    Tamtaji OR; Mobini M; Reiter RJ; Azami A; Gholami MS; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):7788-7795. PubMed ID: 30387141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern-recognition receptors in endometriosis: A narrative review.
    Guo B; Chen JH; Zhang JH; Fang Y; Liu XJ; Zhang J; Zhu HQ; Zhan L
    Front Immunol; 2023; 14():1161606. PubMed ID: 37033937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.
    Dajon M; Iribarren K; Cremer I
    Immunobiology; 2017 Jan; 222(1):89-100. PubMed ID: 27349597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
    Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
    Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-Review: The Non-Immune Functions of Toll-Like Receptors.
    Song Y; Shou LM; Ai LY; Bei Y; Chen MT
    Crit Rev Eukaryot Gene Expr; 2019; 29(1):37-45. PubMed ID: 31002593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.